Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

Povidone Iodine Topical

Phase 3

AAdvantage Silver Dental Arrest, LLC

1

Indications

2

Total Trials

2

Active Trials

0

Competitors

Timeline

Expected Milestones

Q4 2028

ApprovedRecruiting

Infection

NCT06282510

Q1 2029

Not yet recruiting

Dental Caries

NCT07683910

Clinical

Trials by Indication[1]

Infection1 trial

Impact of Nasal Antisepsis on Candida Auris Colonization

Recruiting·MMary K Hayden·Approved·NCT06282510·120 enrolled

Dental Caries1 trial

Sequential Application of PVP-I and Fluoride Varnish: A Prospective Cohort Study

Not yet recruiting·AAdvantage Silver Dental Arrest, LLC··NCT07683910·393 enrolled

Sources

References

[1]
ClinicalTrials.gov — 2 trial records for Povidone Iodine Topical. U.S. National Library of Medicine, National Institutes of Health.
[2]
Open Targets Platform — Drug–disease associations for Povidone Iodine Topical. EMBL-EBI & Wellcome Sanger Institute.
[3]
SEC EDGAR — Advantage Silver Dental Arrest, LLC company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Highest Phase: Phase 3[1]
Company: AAdvantage Silver Dental Arrest, LLC

Related News